Menu Back toS01-Current-Status-of-the-Application-of-Cancer-Genomic-Medicine-Present-and-Future-of-Gene-Panel-Testing

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe


[S01]Current Status of the Application of Cancer Genomic Medicine - Present and Future of Gene panel Testing-

Session Chair(s)

Noboru  Yamamoto, MD, PhD

Noboru Yamamoto, MD, PhD

  • Deputy Director, Department of Experimental Therapeutics
  • National Cancer Center Hospital, Japan
Current Status of the Application of Cancer Genomic Medicine - Present and Future of Gene panel Testing-

Speaker(s)

Noboru  Yamamoto, MD, PhD

Challenges in Genome-Based Cancer Therapy (from Clinical Practice)

Noboru Yamamoto, MD, PhD

  • Deputy Director, Department of Experimental Therapeutics
  • National Cancer Center Hospital, Japan
Naoyuki  Yabana, PhD

Perspectives on Oncology Panels: From Regulatory View

Naoyuki Yabana, PhD

  • Director, Office of In Vitro Diagnostics
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshiaki  Tazawa

Regulatory Issues on Cancer Panel Tests

Yoshiaki Tazawa

  • Part-time Adviser, Foundation Medicine Business Dept.
  • CHUGAI PHARMACEUTICAL CO., LTD., Japan